经过股东多年缠斗，科兴生物如同一座埋藏着百亿美元的金库。眼下，公司的退市危机迫在眉睫，但首笔百亿元现金分红已经先行展开。科兴生物的这场“核弹式”分红，不仅关系着科兴生物各方股东能否获得巨额回报。更关键的是，公司各派股东以“支持分红”和“反对分红”为界限，试图以此拉拢中小股东选票，以保留或争夺科兴生物的董事会席位。在首笔分红推进过程中，选举科兴生物新董事会的特别股东大会举行。按照股东之一赛富基金的...
Source Link经过股东多年缠斗，科兴生物如同一座埋藏着百亿美元的金库。眼下，公司的退市危机迫在眉睫，但首笔百亿元现金分红已经先行展开。科兴生物的这场“核弹式”分红，不仅关系着科兴生物各方股东能否获得巨额回报。更关键的是，公司各派股东以“支持分红”和“反对分红”为界限，试图以此拉拢中小股东选票，以保留或争夺科兴生物的董事会席位。在首笔分红推进过程中，选举科兴生物新董事会的特别股东大会举行。按照股东之一赛富基金的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.